Low circulating IGF-II concentrations predict weight gain and obesity in humans

Diabetes

Volumn 52, Issue 6, 2003, Pages 1403-1408

  Sandhu, Manjinder S ^a   Gibson, J Martin ^b   Heald, Adrian H ^b   Dunger, David B ^c   Wareham, Nicholas J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ADULT; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; WEIGHT GAIN;

BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MIDDLE AGED; OBESITY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; SMOKING; TIME FACTORS; WEIGHT GAIN;

EID: 0037983723     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.6.1403     Document Type: Article

References (50)

1. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16:3-34, 1995
2. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson-Smith A, Fundele R, Stewart F, Kelsey G, Fowden A, Sibley C, Reik W: Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417:945-948, 2002
3. Holly JM: The IGF-II enigma. Growth Horm IGF Res 8:183-184, 1998
4. Wolf E, Hoeflich A, Lahm H: What is the function of IGF-II in postnatal life? Answers from transgenic mouse models. Growth Horm IGF Res 8:185-193, 1998
5. O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, Humphries SE, Day IN: Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 21:822-825, 1997
6. Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD: Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 10:1491-1501, 2001
7. Gu D, O'Dell SD, Chen XH, Miller GJ, Day IN: Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11. Hum Genet 110:173-181, 2002
8. Ukkola O, Sun G, Bouchard C: Insulin-like growth factor 2 (IGF2) and IGF-binding protein 1 (IGFBP1) gene variants are associated with over-feeding-induced metabolic changes. Diabetologia 44:2231-2236, 2001
9. Wareham NJ, Byrne CD, Williams R, Day NE, Hales CN: Fasting proinsulin concentrations predict the development of type 2 diabetes. Diabetes Care 22:262-270, 1999
10. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization, 1985
11. World Health Organization. Definition, Diagnosis and Classification of Diabetes: Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
13. Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E: Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 88:168-173, 1991
14. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H: Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15:314-322, 1999
15. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva, World Health Organization, 1997
16. Kunst A, Draeger B, Ziegenhorn J: UV-methods with hexokinase and glucose-6-phosphate dehydrogenase. In Methods of Enzymatic Analysis. Bergmeyer H, Ed. Deerfield, Weinheim Verlag Chemie, 1983, p. 163-172
17. Sobey WJ, Beer SF, Carrington CA, Clark PM, Frank BH, Gray IP, Luzio SD, Owens DR, Schneider AE, Siddle K: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 260:535-541, 1989
18. Alpha B, Cox L, Crowther N, Clark PM, Hales CN: Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin. Eur J Clin Chem Clin Biochem 30:27-32, 1992
19. Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, Gibson JM: Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44:333-339, 2001
20. Wedick NM, Mayer-Davis EJ, Wingard DL, Addy CL, Barrett-Connor E: Insulin resistance precedes weight loss in adults without diabetes: the Rancho Bernardo Study. Am J Epidemiol 153:1199-1205, 2001
21. Harris TB, Launer LJ, Madans J, Feldman JJ: Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. BMJ 314:1791-1794, 1997
22. Inui A: Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 52:72-91, 2002
23. Reeve AE, Becroft DM, Morison IM, Fukuzawa R: Insulin-like growth factor-II imprinting in cancer. Lancet 359:2050-2051, 2002
24. Le Stunff C, Fallin D, Bougneres P: Paternal transmission of the very common class I INS VNTR alleles predisposes to childhood obesity. Nat Genet 29:96-99, 2001
25. Dunger DB, Ong KK, Huxtable SJ, Sherriff A, Woods KA, Ahmed ML, Golding J, Pembrey ME, Ring S, Bennett ST, Todd JA: Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nat Genet 19:98-100, 1998
26. Lindsay RS, Kobes S, Knowler WC, Hanson RL: Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of birth weight. Hum Genet 110:503-509, 2002
27. Roth SM, Schrager MA, Metter EJ, Riechman SE, Fleg JL, Hurley BF, Ferrell RE: IGF2 genotype and obesity in men and women across the adult age span. Int J Obes Relat Metab Disord 26:585-587, 2002
28. Rice T, Chagnon YC, Perusse L, Borecki IB, Ukkola O, Rankinen T, Gagnon J, Leon AS, Skinner JS, Wilmore JH, Bouchard C, Rao DC: A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: the HERITAGE Family Study. Diabetes 51:848-855, 2002
29. Jones BK, Levorse J, Tilghman SM: Deletion of a nuclease-sensitive region between the Igf2 and H19 genes leads to Igf2 misregulation and increased adiposity. Hum Mol Genet 10:807-814, 2001
30. Cruickshank JK, Heald AH, Anderson S, Cade JE, Sampayo J, Riste LK, Greenhalgh A, Taylor W, Fraser W, White A, Gibson JM: Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol 154:504-513, 2001
31. Chang S, Wu X, Yu H, Spitz MR: Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Cancer Epidemiol Biomarkers Prev 11:758-766, 2002
32. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H: Free insulin-like growth factors in human obesity. Metabolism 44:37-44, 1995
33. Argente J, Caballo N, Barrios V, Munoz MT, Pozo J, Chowen JA, Morande G, Hernandez M: Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation. J Clin Endocrinol Metab 82:2084-2092, 1997
34. Weyer C, Pratley RE, Salbe AD, Bogardus C, Ravussin E, Tataranni PA: Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. J Clin Endocrinol Metab 85:1087-1094, 2000
35. Ravussin E, Gautier JF: Metabolic predictors of weight gain. Int J Obes Relat Metab Disord 23 (Suppl. 1):37-41, 1999
36. Sun G, Ukkola O, Rankinen T, Joanisse DR, Bouchard C: Skeletal muscle characteristics predict body fat gain in response to overfeeding in never-obese young men. Metabolism 51:451-456, 2002
37. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N: Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200, 2001
38. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL: Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157:137-148, 2002
39. O'Dell SD, Day IN: Insulin-like growth factor II (IGF-II). Int J Biochem Cell Biol 30:767-771, 1998
40. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, Neely K, Hintz R: Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 269:13779-13784, 1994
41. Rossetti L, Barzilai N, Chen W, Harris T, Yang D, Rogler CE: Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J Biol Chem 271:203-208, 1996
42. Da Costa TH, Williamson DH, Ward A, Bates P, Fisher R, Richardson L, Hill DJ, Robinson IC, Graham CF: High plasma insulin-like growth factor-II and low lipid content in transgenic mice: measurements of lipid metabolism. J Endocrinol 143:433-439, 1994
43. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM: Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11:107-111, 1988
44. Harel Z, Tannenbaum GS: Centrally administered insulin-like growth factor II fails to alter pulsatile growth hormone secretion or food intake. Neuroendocrinology 56:161-168, 1992
45. Lauterio TJ, Marson L, Daughaday WH, Baile CA: Evidence for the role of insulin-like growth factor II (IGF-II) in the control of food intake. Physiol Behav 40:755-758, 1987
46. Tannenbaum GS, Guyda HJ, Posner BI: Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 220:77-79, 1983
47. Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP: Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 136:5718-5724, 1995
48. Moller DE, Yokota A, Caro JF, Flier JS: Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 3:1263-1269, 1989
49. Lauterio TJ, Aravich PF, Rotwein P: Divergent effects of insulin on insulin-like growth factor-II gene expression in the rat hypothalamus. Endocrinology 126:392-398, 1990
50. Ahmed I, Lauterio TJ: Intracerebroventricular injection of insulin or glucose alters insulin-like growth factor II (IGF-II) concentrations in specific hypothalamic nuclei. Brain Res. 595:242-248, 1992